Financials
Income statement
| Fiscal date | Mar 2025 | Jun 2024 | Mar 2024 |
|---|---|---|---|
| Total reported revenue | 1.8T | 2.1T | 1.2T |
| Cost of revenue | 795.2B | 834.8B | 617.4B |
| Gross profit | 1.0T | 1.2T | 534.6B |
| Operating expense | |||
| Research & development | — | — | — |
| Selling general and admin | 57.0B | 185.6B | 41.2B |
| Other operating expenses | 84.9B | -70.8B | 54.4B |
| Operating income | 357.8B | 614.2B | 150.0B |
| Non operating interest income | |||
| Income | 2.1B | 966M | 2.2B |
| Expense | 46.4B | 49.5B | 35.4B |
| Other income expense | — | — | — |
| Pretax income | 311.6B | 570.6B | 127.6B |
| Tax provision | 85.4B | 123.3B | 40.8B |
| Net income | 226.1B | 447.4B | 86.8B |
| Basic EPS | 0.0 | — | 3.9 |
| Diluted EPS | 0.0 | — | 3.9 |
| Basic average shares | 25.2B | — | 25.2B |
| Diluted average shares | 25.2B | — | 25.2B |
| EBITDA | 566.8B | 793.4B | 290.9B |
| Net income from continuing op. | — | — | — |
| Minority interests | -910M | -14.7B | 12.6B |
| Preferred stock dividends | 0 | 0 | 0 |